Evasion of Host Immune Response by Dengue Virus
登革热病毒逃避宿主免疫反应
基本信息
- 批准号:8556076
- 负责人:
- 金额:$ 19.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Dengue virus core protein attenuates the host IFN response. In order to examine the effect that DENV-C protein has on induction of type I IFN, expression vectors were constructed containing the DENV-C gene. After transfection of HEK293 cells with the DENV-C expression vector, cells were treated with poly (I:C) and subsequently monitored for induction of IFN by qRT-PCR. Cells expressing the DENV-C protein showed decreased levels of IFN-beta expression when compared to mock transfected controls. A similar phenotype was observed using other cell types Huh7 and A549. In addition, overexpression of DENV-C decreased AV activity as measured by viral titers after treatment with poly (I:C). Components of the IFN-beta enhanceosome were examined by western blot analysis. No observable differences were detected in either the amount or phosphorylation of IRF3, NF-kappa B or c-Jun, indicating that these proteins were not responsible for the observed phenotype
Dengue virus core protein interacts with host proteins. Possible interaction partners for DENV-C were identified by co-immunoprecipitation (Co-IP), followed by mass spectrometry (MS). MS identified a number of possible host interaction partners. Results were then verified by Co-IP and reverse Co-IP followed by western blot analysis. Virus-host protein interactions were also verified by examining co-localization by confocal microscopy. The cellular protein NF45was determined to interact with DENV-C.
Mutations in the DENV-C gene affect its ability to abrogate the host IFN response. A number of mutations were introduced into the DENV-C gene using site directed mutagenesis. The DENV-C mutants were then examined for their ability to abrogate induction of type I IFN after treatment with Poly(I:C). Mutations in the N-terminus appear to affect the observed phenotype of DENV-C. In addition, localization of DENV-C and mutants were observed by confocal microscopy. Mutations to the N-terminus of the protein affect the nuclear localization of DENV-C, indicating that the N-terminus is important for the affect that DENV-C has on induction of type I IFN either through mediating interactions with specific host proteins, or by influencing the localization of the DENV-C protein.
登革热病毒核心蛋白减弱了宿主IFN反应。为了检查DENV-C蛋白对I型IFN诱导的影响,构建了包含DENV-C基因的表达载体。 用DENV-C表达载体转染HEK293细胞后,用Poly(I:C)处理细胞,然后对QRT-PCR进行监测以诱导IFN。 与模拟转染的对照相比,表达DENV-C蛋白的细胞显示IFN-β表达水平降低。 使用其他细胞类型HUH7和A549观察到类似的表型。另外,通过使用Poly(I:C)处理后,通过病毒滴度测量的DENV-C的过表达降低了AV活性。 通过Western印迹分析检查了IFN-β增强体的成分。 在IRF3,NF-KAPPA B或C-JUN的量或磷酸化中未检测到可观察到的差异,这表明这些蛋白质对观察到的表型不负责
登革热病毒核心蛋白与宿主蛋白相互作用。通过共免疫沉淀(CO-IP)鉴定出DENV-C的可能相互作用伙伴,然后进行质谱(MS)。 MS确定了许多可能的主机交互合作伙伴。 然后通过co-IP和反向co-IP验证结果,然后进行蛋白质印迹分析。病毒宿主蛋白相互作用还通过共聚焦显微镜检查共定位来验证。 细胞蛋白NF45WAS确定与DENV-C相互作用。
DENV-C基因中的突变会影响其消除宿主IFN反应的能力。使用位点的诱变将许多突变引入DENV-C基因中。 然后检查了DENV-C突变体,以消除用Poly(I:C)治疗后的I型IFN诱导的能力。 N末端中的突变似乎影响了观察到的DENV-C的表型。 另外,通过共聚焦显微镜观察到DENV-C和突变体的定位。 蛋白质N末端的突变会影响DENV-C的核定位置,表明N末端对于DENV-C通过与特定宿主蛋白的相互作用或影响DENV-C-C蛋白的定位而对I型IFN诱导的影响很重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Kathryn Zoon的其他基金
Mechanisms of Antitumor Action of Human Interferon
人干扰素的抗肿瘤作用机制
- 批准号:89464348946434
- 财政年份:
- 资助金额:$ 19.16万$ 19.16万
- 项目类别:
Novel Human Interferons Produced by Protein Engineering
蛋白质工程生产的新型人类干扰素
- 批准号:83361838336183
- 财政年份:
- 资助金额:$ 19.16万$ 19.16万
- 项目类别:
Novel Human Interferons Produced by Protein Engineering
蛋白质工程生产的新型人类干扰素
- 批准号:81569628156962
- 财政年份:
- 资助金额:$ 19.16万$ 19.16万
- 项目类别:
Infectious Diseases and Allergy Scientific Education and Outreach
传染病和过敏科学教育和推广
- 批准号:85561928556192
- 财政年份:
- 资助金额:$ 19.16万$ 19.16万
- 项目类别:
The Antiviral Activities of Human Interferons
人干扰素的抗病毒活性
- 批准号:83362598336259
- 财政年份:
- 资助金额:$ 19.16万$ 19.16万
- 项目类别:
Infectious Diseases and Allergy Scientific Education and Outreach
传染病和过敏科学教育和推广
- 批准号:77326977732697
- 财政年份:
- 资助金额:$ 19.16万$ 19.16万
- 项目类别:
The Antiviral Activities of Human Interferons
人干扰素的抗病毒活性
- 批准号:81570368157036
- 财政年份:
- 资助金额:$ 19.16万$ 19.16万
- 项目类别:
Activation, Maintenance and Certification of Infectious Diseases Labs
传染病实验室的激活、维护和认证
- 批准号:85561918556191
- 财政年份:
- 资助金额:$ 19.16万$ 19.16万
- 项目类别:
Infectious Diseases and Allergy Scientific Education and Outreach
传染病和过敏科学教育和推广
- 批准号:87458108745810
- 财政年份:
- 资助金额:$ 19.16万$ 19.16万
- 项目类别:
Mechanisms of Antiviral Action of Human Interferon-alpha
人干扰素-α的抗病毒作用机制
- 批准号:89464358946435
- 财政年份:
- 资助金额:$ 19.16万$ 19.16万
- 项目类别:
相似国自然基金
面向康复护理机器人的人机信任度评估方法与任务影响机制研究
- 批准号:62306195
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
长期护理保险制度与老年照护供给效率及公平:影响机制与政策措施
- 批准号:72274117
- 批准年份:2022
- 资助金额:45.00 万元
- 项目类别:面上项目
长期护理保险制度与老年照护供给效率及公平:影响机制与政策措施
- 批准号:
- 批准年份:2022
- 资助金额:45 万元
- 项目类别:面上项目
深海土阻力时变特性影响下管线轴向走管的变形机理及防护理论研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
深海土阻力时变特性影响下管线轴向走管的变形机理及防护理论研究
- 批准号:52101325
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Genetic and Pharmacological Manipulation of KSR in KRAS-driven Cancer
KSR 在 KRAS 驱动的癌症中的遗传和药理学操作
- 批准号:1020754310207543
- 财政年份:2018
- 资助金额:$ 19.16万$ 19.16万
- 项目类别:
Nanoimmunoliposome-Complexed SPIO: Tumor-Specific Detection of Early Lung Cancer
纳米免疫脂质体复合 SPIO:早期肺癌的肿瘤特异性检测
- 批准号:73634247363424
- 财政年份:2008
- 资助金额:$ 19.16万$ 19.16万
- 项目类别: